Atrial Fibrillation registry to Follow the long-teRm Outcomes and the use of aNTIcoagulants aftER Ablatio
Not Applicable
- Conditions
- Atrial fibrillation
- Registration Number
- JPRN-UMIN000026849
- Lead Sponsor
- Division of Cardiology, Department of Medicine, Nihon University School of Medicine
- Brief Summary
2800 patients were enrolled.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3400
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients contraindicated for direct oral anticoagulants 2) Patients who had acute myocardial infartion or stroke/TIA within 2 months before ablation 3) Patients judged as inappropriate for this study by investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composite of symptomatic stroke (ischemic or hemorrhagic) and systemic embolism
- Secondary Outcome Measures
Name Time Method Discontinuation of anticoagulant drugs Atrial fibrillation recurrence after the blanking period Major adverse cardiac events (myocardial infarction/unstable angina pectoris and heart failure) All cause of death Major bleeding(adapeted ISTH standard)